US research roundup: Eli Lilly, Netflix and Zscaler
LLY•Analysts raised Leerink Partners’ Eli Lilly price target to $1,316 from $1,309, cut several Netflix targets, and initiated Zscaler coverage at neutral with a $215 target.
1. Analyst target changes
Leerink Partners raised its Eli Lilly target price to $1,316 from $1,309. For Netflix, Canaccord Genuity cut its target to $110 from $125, while Evercore ISI and MoffettNathanson set targets of $90 and Morgan Stanley and Piper Sandler lowered theirs to $77 and $78, respectively. D.A. Davidson initiated coverage of Zscaler with a neutral rating and a $215 price target.
2. Other research actions
The roundup also lists analyst rating and target-price changes for numerous other US-listed companies, including target cuts for General Motors and GE Aerospace and target increases for Intuitive Surgical.
